Loading…

Bilateral nodule radiofrequency ablation in a single setting: First reported case series

BackgroundRadiofrequency ablation (RFA) is a minimally‐invasive ablative technique with an impressive safety profile used to manage thyroid nodules. Current reports with RFA describe the treatment of a single nodule in a single‐setting. We describe the first series of bilateral nodule RFA in a singl...

Full description

Saved in:
Bibliographic Details
Published in:Head & neck 2023-11, Vol.45 (11), p.2749-2753
Main Authors: Issa, Peter P., Magazine, Brandon M., LaForteza, Alexandra, Shama, Mohamed, Kandil, Emad
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:BackgroundRadiofrequency ablation (RFA) is a minimally‐invasive ablative technique with an impressive safety profile used to manage thyroid nodules. Current reports with RFA describe the treatment of a single nodule in a single‐setting. We describe the first series of bilateral nodule RFA in a single‐setting.MethodsRFA was performed on patients with bilateral thyroid nodules in a single‐setting. A cohort of randomly selected patients undergoing RFA for bilateral thyroid nodules in a separate setting was reported as a control cohort.ResultsA total of 12 patients were included in our series, included 6 patients in the single‐setting ablation cohort. For patients with bilateral nodules treated by RFA in a separate setting, the mean volume reduction rate (VRR) at 6 months of 63.79% ± 18.86%. There were no reports of complications in the separate setting cohort. For patients with bilateral nodules treated by RFA in a single‐setting, the mean VRR at 6 months was 64.% ± 18.97%. There were no reports of complications in the single‐setting cohort.ConclusionsOur work describes a novel use of RFA, providing preliminary insight into its use for appropriately selected patients with bilateral thyroid nodules. Future studies with larger sample sizes are warranted to corroborate and expand on our findings.
ISSN:1043-3074
1097-0347
DOI:10.1002/hed.27494